title: CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin.
authors.affiliation: Department of Haematology, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.
authors.forename: W N
authors.initials: WN
authors.lastname: Patton
authors.forename: C
authors.initials: C
authors.lastname: Carter
authors.forename: N
authors.initials: N
authors.lastname: Bienz
authors.forename: T
authors.initials: T
authors.lastname: Lamb
authors.forename: B J
authors.initials: BJ
authors.lastname: Boughton
authors.forename: I M
authors.initials: IM
authors.lastname: Franklin
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003131:Combined Modality Therapy; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000517:prevention & control* / Q000635:transmission; D004341:Drug Evaluation; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007116:Immunization, Passive; D011658:Pulmonary Fibrosis / Q000517:prevention & control*; D014184:Transplantation, Homologous
chemical_list: D015774:Ganciclovir